GLUT1 is frequently overexpressed in cancer (Szablewski, 2013), which can be attributed to the limited uptake of glucose, even when insufficient glucose is available due to the continuous growth of the tumor (Barron et al., 2016). The gene discussed is SLC2A1; the disease is neoplasm.